Ceribell (CBLL) Non-Current Assets (2023 - 2026)
Ceribell's (CBLL) quarterly Non-Current Assets came in at $9.2 million in Q1 2026, up 13.86% YoY from $8.1 million in Q1 2025, and up 0.9% on a QoQ basis from $9.1 million in Q4 2025.
Ceribell (CBLL) Non-Current Assets (2023 - 2026) Analysis & Trends
Ceribell (CBLL) has 4 years of Non-Current Assets data on file, last reported at $9.2 million in Q1 2026.
- Quarterly Non-Current Assets rose 13.86% year-over-year to $9.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.9 million (down 3.9% YoY) and the FY2025 annual result came in at $9.1 million, up 11.61% from the prior year.
- Non-Current Assets improved to $9.2 million in Q1 2026, from $9.1 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $12.1 million in Q3 2024 to a low of $7.0 million in Q4 2023.
- A 4-year average of $8.6 million and a median of $8.1 million in 2024 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2024 — Non-Current Assets increased 16.97% — and 2025, when it slumped 36.2%.
- Tracing CBLL's Non-Current Assets over 4 years: stood at $7.0 million in 2023, then advanced by 16.97% to $8.1 million in 2024, then grew by 11.61% to $9.1 million in 2025, then increased by 0.9% to $9.2 million in 2026.
- The last three Non-Current Assets figures came in at $9.2 million (Q1 2026), $9.1 million (Q4 2025), and $7.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Ceribell | 921.90 Mn | 792.63 Mn | 25.94 Mn | 8.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.50 Mn |
| Mar 31, 2026 | 9.17 Mn |
| Dec 31, 2025 | 9.09 Mn |
| Sep 30, 2025 | 7.72 Mn |
| Jun 30, 2025 | 7.90 Mn |
| Mar 31, 2025 | 8.05 Mn |
| Dec 31, 2024 | 8.14 Mn |
| Sep 30, 2024 | 12.10 Mn |
| Dec 31, 2023 | 6.96 Mn |